knowledge -WSS

knowledge

author：fashion 2025-09-28 01:30:45 - browse：8

The FDA building -- First Opinion coverage from STAT — Adobe

The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakier ground following a Food and Drug Administration advisory committee meeting Thursday.

Regulatory advisers voted 10-2 that the data on the company’s drug Lumakras, a treatment for lung cancer, could not be properly assessed. Lumakras targets a specific mutation to a protein called KRAS, which is one of the most common genetic mutations in cancer.

The vote comes as Amgen is hoping to convert a conditional approval for the drug to a full approval based on a 345-person study called CodeBreaK 200, in which Lumakras met the primary endpoint, delaying tumor growth approximately five weeks longer than the standard of care medication, docetaxel. The drug didn’t extend patients’ overall survival.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Drinking water from half of US faucets contains PFAS: Study

hotspot

WSS

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Trump seeks lengthy delay of classified docs trial, citing upcoming election

California man arrested in connection with serial murders of Mexican strip club workers

Pig kidney works a record two months in donated body

Long Covid needs a new name — and a new frame

North Korean leader's powerful sister says warplanes repelled US spy plane

focus

knowledge

Wikipedia

23andMe had bad news about my health. I wish a person had delivered it

Diverse clinical trials: Why aren’t we there yet?

State Dept. review finds Biden bears some blame for Afghanistan failures

Drinking water from half of US faucets contains PFAS: Study

Guidelines to prevent youth baseball injuries need more muscle

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Wildfire smoke exposes gaps in outdoor worker protections

Neutralizing antibodies against HIV shows promise in children

Heart attack and stroke risk calculators need revising

Telehealth for opioid use disorder is lifesaving

hotspot

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Rare Northern Lights show in US this week: Where and how to see it

How medical schools plan to diversify without affirmative action

Popular nasal decongestant doesn't actually relieve congestion

FDA proposes changes to key medical devices approval pathway

UPS workers' union leader explains what's at stake as strike edges closer

leisure time

hotspot

focus

leisure time